RenovoRx Inc(RNXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RNXT RenovoRx Inc

Trading 11-12 14:08:10 EST

1.16

-0.06

-4.92%

High1.22	Low1.10	Vol377.14K
Open1.21	D1 Closing1.22	Amplitude9.84%
Mkt Cap55.97M	Tradable Cap49.22M	Total Shares48.25M
T/O437.24K	T/O Rate0.89%	Tradable Shares42.43M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RNXT","market":"US","secType":"STK","nameCN":"RenovoRx Inc","latestPrice":1.16,"timestamp":1794510459152,"preClose":1.22,"halted":0,"volume":377142,"delay":0,"changeRate":-0.04918032786885251,"floatShares":42429100,"shares":48250592,"eps":-0.306281,"marketStatus":"Trading","change":-0.06,"latestTime":"11-12 14:08:10 EST","open":1.21,"high":1.22,"low":1.1,"amount":437244.9708306,"amplitude":0.098361,"askPrice":1.18,"askSize":1,"bidPrice":1.16,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-0.306281,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1794517200000},"marketStatusCode":2,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":1.22,"preHourTrading":{"tag":"盘前","latestPrice":1.2899,"preClose":1.22,"latestTime":"09:05 EST","volume":59,"amount":70.4991944,"timestamp":1794492327209,"change":0.0699,"changeRate":0.057295,"amplitude":0.090082},"postHourTrading":{"tag":"盘后","latestPrice":1.2,"preClose":1.22,"latestTime":"19:53 EST","volume":1625,"amount":1929.3314,"timestamp":1794444835405,"change":-0.02,"changeRate":-0.016393,"amplitude":0.050984},"volumeRatio":0.740939},"requestUrl":"/m/hq/s/RNXT/tweets","defaultTab":"tweets","newsList":[{"id":"2682558498","title":"RenovoRx Raises 2026 Revenue Outlook to $3.75 Million-$4.25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682558498","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682558498?lang=en_us&edition=fundamental","pubTime":"2026-11-12 03:29","pubTimestamp":1794425348,"startTime":"0","endTime":"0","summary":"RenovoRx raises 2026 revenue outlook to $3.75 million-$4.25 millionRenovoRx forecasts 2026 revenue of $3.75 million to $4.25 million.Third-quarter revenue reached $1.07 million, more than quadrupling ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nNDL3G70DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682396805","title":"RenovoRx Price Target Raised to $15.00/Share from $14.50 by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2682396805","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682396805?lang=en_us&edition=fundamental","pubTime":"2026-11-09 17:14","pubTimestamp":1794215640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNXT/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681916508","title":"RenovoRx’s Growing Commercial Traction and Pipeline Expansion Support Buy Rating; $3 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2681916508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681916508?lang=en_us&edition=fundamental","pubTime":"2026-11-07 03:36","pubTimestamp":1793993794,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on RenovoRx today and set a price target of $3.00. Swayampakula Ramakanth ha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/renovorxs-growing-commercial-traction-and-pipeline-expansion-support-buy-rating-3-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/renovorxs-growing-commercial-traction-and-pipeline-expansion-support-buy-rating-3-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681819889","title":"RenovoRx Inc Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2681819889","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681819889?lang=en_us&edition=fundamental","pubTime":"2026-11-06 07:28","pubTimestamp":1793921306,"startTime":"0","endTime":"0","summary":"RenovoRx Inc reports results for the quarter ended September 30 - Earnings SummaryRenovoRx IncRNXT.OQreported a quarterly adjusted loss of 7 cents per share for the quarter ended September 30, higher ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL5N46M3HD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681588691","title":"RenovoRx reports Q3 EPS (7c), consensus (5c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2681588691","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681588691?lang=en_us&edition=fundamental","pubTime":"2026-11-06 06:50","pubTimestamp":1793919030,"startTime":"0","endTime":"0","summary":"Reports Q3 revenue $1.07M, consensus $1.06M. “We generated record results in the third quarter as revenue exceeded the million-dollar threshold and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovorx-reports-q3-eps-7c-consensus-5c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovorx-reports-q3-eps-7c-consensus-5c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681288694","title":"RenovoRx backs FY26 revenue view $3.75M-$4.25M, consensus $3.87M","url":"https://stock-news.laohu8.com/highlight/detail?id=2681288694","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681288694?lang=en_us&edition=fundamental","pubTime":"2026-11-06 06:50","pubTimestamp":1793919025,"startTime":"0","endTime":"0","summary":"The company said, “RenovoRx (RNXT) is maintaining its full-year 2026 revenue guidance of $3.75 million to $4.25 million, which implies year-over-ye...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovorx-backs-fy26-revenue-view-3-75m-4-25m-consensus-3-87m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovorx-backs-fy26-revenue-view-3-75m-4-25m-consensus-3-87m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681688362","title":"RenovoRx Q3 Revenue Jumps Nearly 300% on Cancer Center Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2681688362","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681688362?lang=en_us&edition=fundamental","pubTime":"2026-11-06 06:07","pubTimestamp":1793916458,"startTime":"0","endTime":"0","summary":"RenovoRx Q3 revenue jumps nearly 300% on cancer center growthOverviewU.S. life sciences firm's Q3 revenue rose nearly 300% yr/yr on RenovoCath adoptionCompany maintained 2026 annual revenue guidance o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL2N46M1KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","BK4139","IE00BJJMRZ35.SGD","BK4167","RVMD","IE0009354923.USD","IDNA","BK4539","IE00B4R5TH58.HKD","RNXT","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0009355771.USD","PTH","EVH","LU0320765992.SGD","LU0053671581.USD","IE00B2B36J28.USD","BBH","IE00BFTCPJ56.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681192000","title":"RenovoRx Q3 2026 Net Loss Widens 25% Year over Year to $3.65 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681192000","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681192000?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:34","pubTimestamp":1793914478,"startTime":"0","endTime":"0","summary":"RenovoRx Q3 2026 net loss widens 25% year over year to $3.65 millionRenovoRx’s third-quarter 2026 net loss widened 25% year over year to $3.65 million.Revenue rose year over year to $1.07 million, dri","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nNDLtN8Pl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","SG9999014005.SGD","RNXT","LU2210150020.SGD","SG9999014013.SGD","IE00BN0W2T93.GBP","NDAQ","BK4585","BK4539","BCDF","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BQXX3F31.USD","LU0314104364.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4139","IE00BN0W2W23.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","IE00BQXX3C00.GBP","BK4112","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681002596","title":"RenovoRx Q3 Adj. EPS $(0.08) Misses $(0.06) Estimate, Sales $1.066M Beat $1.065M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2681002596","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681002596?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:09","pubTimestamp":1793912976,"startTime":"0","endTime":"0","summary":"RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is unchanged from the same period last year.  The company reported","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/62950466/renovorx-q3-adj-eps-0-08-misses-0-06-estimate-sales-1-066m-beat-1-065m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681004024","title":"RenovoRx Q3 Net Income USD -3.647 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681004024","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681004024?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:06","pubTimestamp":1793912777,"startTime":"0","endTime":"0","summary":"BRIEF-RenovoRx Q3 Net Income USD -3.647 MillionNov 05 (Reuters) - RenovoRx Q3 operating expenses USD 4.114 million.Q3 basic EPS USD -0.08Q3 EPS USD -0.08","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLXNCDJ8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681300428","title":"RenovoRx Q3 Operating Expenses USD 4.114 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681300428","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681300428?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:05","pubTimestamp":1793912717,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLXNCDJ8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681041310","title":"RenovoRx Q3 Basic EPS USD -0.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2681041310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681041310?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:05","pubTimestamp":1793912717,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLXNCDJ8W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681044390","title":"RenovoRx Reports Record Third Quarter 2026 Revenue Exceeding $1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681044390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681044390?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:05","pubTimestamp":1793912717,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nTUA1MTXC4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678460480","title":"RenovoRx to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2678460480","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678460480?lang=en_us&edition=fundamental","pubTime":"2026-10-28 20:31","pubTimestamp":1793190690,"startTime":"0","endTime":"0","summary":"RenovoRx to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumRenovoRx will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDL1QrlKB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2210150020.SGD","IE00BN0W2V16.EUR","BK4112","IE00BKPKM429.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU0314104364.USD","BK4588","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4139","SG9999014039.USD","RNXT","IE00BQXX3F31.USD","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","SG9999014005.SGD","BK4585","LU2095319765.USD","BCDF","NDAQ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677963248","title":"RenovoRx Schedules Third-Quarter 2026 Financial Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2677963248","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677963248?lang=en_us&edition=fundamental","pubTime":"2026-10-22 20:45","pubTimestamp":1792673117,"startTime":"0","endTime":"0","summary":"RenovoRx schedules third-quarter 2026 financial results releaseRenovoRx will release third-quarter 2026 financial results and business highlights on November 5, 2026, after market close.A conference c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nNDL1sL83L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","SG9999014039.USD","BK4139","LU0314104364.USD","LU2210150020.SGD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014005.SGD","RNXT","BK4112","BCDF","IE00B64PRP62.GBP","SG9999014013.SGD","LU2095319765.USD","BK4588","BK4539","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BQXX3F31.USD","BK4585","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673601819","title":"RenovoRx Advances Tamp™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated Prism-Tamp Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673601819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673601819?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA1PSSFX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673097793","title":"Here's Why We're Watching RenovoRx's (NASDAQ:RNXT) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673097793","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673097793?lang=en_us&edition=fundamental","pubTime":"2026-10-07 18:36","pubTimestamp":1791369397,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rnxt/renovorx/news/heres-why-were-watching-renovorxs-nasdaqrnxt-cash-burn-situa-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rnxt/renovorx/news/heres-why-were-watching-renovorxs-nasdaqrnxt-cash-burn-situa-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RNXT","QDTE","PSQ","QID","QQQM","QQQA","03086","IYW","FTEC","MNQmain","TECS","QQQY","JEPQ","ONEQ","QQQE","NVIW.SI",".IXIC","BK4539","BK4139","QQQJ","QLD","NQmain","GPIQ","QYLG","SQQQ","TQQY","QQQ","TQQQ","NDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672757619","title":"RenovoRx announces publication on TAMP platform’s potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2672757619","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672757619?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:55","pubTimestamp":1790859337,"startTime":"0","endTime":"0","summary":"RenovoRx (RNXT) announced the publication of a peer-reviewed case series in Case Reports in Oncology from researchers at Hackensack Meridian Health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovorx-announces-publication-on-tamp-platforms-potential-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovorx-announces-publication-on-tamp-platforms-potential-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672875225","title":"RenovoRx Cites Peer-Reviewed Case Series on TAMP Gemcitabine Delivery in Locally Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672875225","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672875225?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:32","pubTimestamp":1790857968,"startTime":"0","endTime":"0","summary":"RenovoRx cites peer-reviewed case series on TAMP gemcitabine delivery in locally advanced pancreatic cancerRenovoRx announced a peer-reviewed case series publication on its TAMP platform using the Ren","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL4F8XxD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014021.USD","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4585","IE00BQXX3F31.USD","SG9999014039.USD","IE00BN0W2T93.GBP","BCDF","SG9999014005.SGD","RNXT","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00BQXX3D17.EUR","LU0314104364.USD","BK4539","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","LU2095319765.USD","BK4588","BK4112","IE00BN0W2W23.USD","BK4139","LU2210150020.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664893587","title":"RenovoRx to Present at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664893587","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664893587?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:16","pubTimestamp":1788318993,"startTime":"0","endTime":"0","summary":"RenovoRx to present at H.C. Wainwright Global Investment ConferenceRenovoRx will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York, September 14-16, 2026.CEO Shaun Bagai and CFO Mark Voll are scheduled to present on September 14 at 1:30 p.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief on September 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5p76xQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.renovorx.com;renovorx.com","stockEarnings":[{"period":"1week","weight":-0.0687},{"period":"1month","weight":-0.024},{"period":"3month","weight":-0.0317},{"period":"6month","weight":0.4878},{"period":"1year","weight":0.1402},{"period":"ytd","weight":0.4522}],"compareEarnings":[{"period":"1week","weight":-0.0091},{"period":"1month","weight":-0.0235},{"period":"3month","weight":-0.0232},{"period":"6month","weight":0.0279},{"period":"1year","weight":0.1125},{"period":"ytd","weight":0.1142}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.049533},{"month":2,"riseRate":0.6,"avgChangeRate":0.102207},{"month":3,"riseRate":0.2,"avgChangeRate":-0.093103},{"month":4,"riseRate":0,"avgChangeRate":-0.163527},{"month":5,"riseRate":0.6,"avgChangeRate":0.050959},{"month":6,"riseRate":0.6,"avgChangeRate":0.043263},{"month":7,"riseRate":0.2,"avgChangeRate":-0.031811},{"month":8,"riseRate":0.4,"avgChangeRate":0.107266},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.07368},{"month":10,"riseRate":0,"avgChangeRate":-0.125136},{"month":11,"riseRate":0.5,"avgChangeRate":0.009801},{"month":12,"riseRate":0.6,"avgChangeRate":0.479671}],"exchange":"NASDAQ","name":"RenovoRx Inc","nameEN":"RenovoRx Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RenovoRx Inc(RNXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest RenovoRx Inc(RNXT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"RenovoRx Inc,RNXT,RenovoRx Inc股票,RenovoRx Inc股票老虎,RenovoRx Inc股票老虎国际,RenovoRx Inc行情,RenovoRx Inc股票行情,RenovoRx Inc股价,RenovoRx Inc股市,RenovoRx Inc股票价格,RenovoRx Inc股票交易,RenovoRx Inc股票购买,RenovoRx Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RenovoRx Inc(RNXT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest RenovoRx Inc(RNXT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}